AssetMark Inc’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.37K Buy
+63
New +$3.76K ﹤0.01% 2811
2025
Q1
– Sell
-1
Closed -$185 – 2683
2024
Q4
$185 Buy
+1
New +$194 ﹤0.01% 2484
2024
Q3
– Sell
-11
Closed -$1.47K – 2318
2024
Q2
$1.47K Sell
11
-2,803
-100% -$530K ﹤0.01% 1795
2024
Q1
$604K Sell
2,814
-2,204
-44% -$432K ﹤0.01% 805
2023
Q4
$1.02M Buy
5,018
+494
+11% +$80K ﹤0.01% 674
2023
Q3
$898K Buy
4,524
+556
+14% +$140K ﹤0.01% 636
2023
Q2
$1.29M Buy
3,968
+78
+2% +$22.3K 0.01% 561
2023
Q1
$911K Sell
3,890
-23
-0.6% -$5.81K ﹤0.01% 616
2022
Q4
$986K Buy
3,913
+288
+8% +$61.4K ﹤0.01% 585
2022
Q3
$643K Buy
3,625
+263
+8% +$52.9K ﹤0.01% 615
2022
Q2
$614K Buy
3,362
+521
+18% +$104K ﹤0.01% 598
2022
Q1
$729K Buy
2,841
+1,382
+95% +$316K ﹤0.01% 546
2021
Q4
$336K Buy
1,459
+1,319
+942% +$322K ﹤0.01% 613
2021
Q3
$33K Buy
+140
New +$29.2K ﹤0.01% 855

Other funds holding INSP

AssetMark Inc's INSP Position: Q3 2026 in Review

AssetMark Inc opened a new position in Inspire Medical Systems (INSP) in Q3 2026: 63 shares worth $4.37K. The stake represents ﹤0.01% of the portfolio and ranks #2811 among its holdings. This is a return to the name: AssetMark Inc previously reported a position in INSP as recently as Q4 2024.

AssetMark Inc first reported a position in INSP in Q3 2021 and has held it in 14 quarters since. The position peaked at $1.29M in Q2 2023. 126 funds tracked by Wall St. Rank hold INSP as of Q3 2026.

  • AssetMark Inc held 63 shares of Inspire Medical Systems worth $4.37K as of Q3 2026.
  • Inspire Medical Systems was a new AssetMark Inc position in Q3 2026.
  • Inspire Medical Systems made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #2811 holding.
  • AssetMark Inc first reported a position in Inspire Medical Systems in Q3 2021 and has held it in 14 quarters since.
  • AssetMark Inc's Inspire Medical Systems position peaked at $1.29M in Q2 2023.
  • 126 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.